
### [MONDO:0001741](http://purl.obolibrary.org/obo/MONDO_0001741)
**Label:** hyperparathyroidism

**Subclasses:** [MONDO:0015897](http://purl.obolibrary.org/obo/MONDO_0015897) (rare hyperparathyroidism), [MONDO:0015027](http://purl.obolibrary.org/obo/MONDO_0015027) (familial isolated hyperparathyroidism), [MONDO:0016166](http://purl.obolibrary.org/obo/MONDO_0016166) (genetic hyperparathyroidism), [MONDO:0009397](http://purl.obolibrary.org/obo/MONDO_0009397) (neonatal severe primary hyperparathyroidism), [MONDO:0016365](http://purl.obolibrary.org/obo/MONDO_0016365) (familial primary hyperparathyroidism), [MONDO:0020523](http://purl.obolibrary.org/obo/MONDO_0020523) (familial parathyroid adenoma), [MONDO:0020524](http://purl.obolibrary.org/obo/MONDO_0020524) (primary parathyroid hyperplasia), [MONDO:0007768](http://purl.obolibrary.org/obo/MONDO_0007768) (hyperparathyroidism-jaw tumor syndrome), [MONDO:0010837](http://purl.obolibrary.org/obo/MONDO_0010837) (primary hyperparathyroidism (disease)), [MONDO:0007767](http://purl.obolibrary.org/obo/MONDO_0007767) (hyperparathyroidism 1), [MONDO:0007540](http://purl.obolibrary.org/obo/MONDO_0007540) (multiple endocrine neoplasia type 1), [MONDO:0012004](http://purl.obolibrary.org/obo/MONDO_0012004) (parathyroid gland carcinoma), [MONDO:0012406](http://purl.obolibrary.org/obo/MONDO_0012406) (HRPT3), 

**Corr. equiv. classes:** [Orphanet:208596](http://www.orpha.net/ORDO/Orphanet_208596), [Orphanet:99880](http://www.orpha.net/ORDO/Orphanet_99880), [Orphanet:143](http://www.orpha.net/ORDO/Orphanet_143), [OMIM:600166](http://purl.obolibrary.org/obo/OMIM_600166), [Orphanet:652](http://www.orpha.net/ORDO/Orphanet_652), [Orphanet:181408](http://www.orpha.net/ORDO/Orphanet_181408), [OMIM:610071](http://purl.obolibrary.org/obo/OMIM_610071), [OMIM:617343](http://purl.obolibrary.org/obo/OMIM_617343), [OMIM:131100](http://purl.obolibrary.org/obo/OMIM_131100), [OMIM:145000](http://purl.obolibrary.org/obo/OMIM_145000), [OMIM:145001](http://purl.obolibrary.org/obo/OMIM_145001), [Orphanet:99877](http://www.orpha.net/ORDO/Orphanet_99877), [Orphanet:99878](http://www.orpha.net/ORDO/Orphanet_99878), [OMIM:608266](http://purl.obolibrary.org/obo/OMIM_608266), [Orphanet:99879](http://www.orpha.net/ORDO/Orphanet_99879), [Orphanet:417](http://www.orpha.net/ORDO/Orphanet_417), [Orphanet:2207](http://www.orpha.net/ORDO/Orphanet_2207), [OMIM:239200](http://purl.obolibrary.org/obo/OMIM_239200), 

**Class expressions from DL-Learner:**

- [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) 59.53%
- [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) and [HP:0040077](http://purl.obolibrary.org/obo/HP_0040077) (Abnormal concentration of calcium in blood) 59.53%
- [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) and [HP:0011767](http://purl.obolibrary.org/obo/HP_0011767) (Abnormality of the parathyroid physiology) 59.53%
- [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) and [HP:0010929](http://purl.obolibrary.org/obo/HP_0010929) (Abnormality of cation homeostasis) 59.53%
- [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) and [HP:0010927](http://purl.obolibrary.org/obo/HP_0010927) (Abnormality of divalent inorganic cation homeostasis) 59.53%
- [HP:0004363](http://purl.obolibrary.org/obo/HP_0004363) (Abnormality of calcium homeostasis) and [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) 59.53%
- [HP:0003111](http://purl.obolibrary.org/obo/HP_0003111) (Abnormality of ion homeostasis) and [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) 59.53%
- [HP:0003072](http://purl.obolibrary.org/obo/HP_0003072) (Hypercalcemia) and [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) 59.53%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) 59.53%
- [HP:0000843](http://purl.obolibrary.org/obo/HP_0000843) (Hyperparathyroidism) and [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) 59.53%
- [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) and [HP:0011767](http://purl.obolibrary.org/obo/HP_0011767) (Abnormality of the parathyroid physiology) and [HP:0040077](http://purl.obolibrary.org/obo/HP_0040077) (Abnormal concentration of calcium in blood) 59.53%
- [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) and [HP:0010929](http://purl.obolibrary.org/obo/HP_0010929) (Abnormality of cation homeostasis) and [HP:0011767](http://purl.obolibrary.org/obo/HP_0011767) (Abnormality of the parathyroid physiology) 59.53%
- [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) and [HP:0010927](http://purl.obolibrary.org/obo/HP_0010927) (Abnormality of divalent inorganic cation homeostasis) and [HP:0011767](http://purl.obolibrary.org/obo/HP_0011767) (Abnormality of the parathyroid physiology) 59.53%
- [HP:0004363](http://purl.obolibrary.org/obo/HP_0004363) (Abnormality of calcium homeostasis) and [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) and [HP:0011767](http://purl.obolibrary.org/obo/HP_0011767) (Abnormality of the parathyroid physiology) 59.53%
- [HP:0003111](http://purl.obolibrary.org/obo/HP_0003111) (Abnormality of ion homeostasis) and [HP:0006780](http://purl.obolibrary.org/obo/HP_0006780) (Parathyroid carcinoma) and [HP:0011767](http://purl.obolibrary.org/obo/HP_0011767) (Abnormality of the parathyroid physiology) 59.53%


